The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study

por Peeters, Marthe C.M., Zwinkels, Hanneke, Koekkoek, Johan A.F., Vos, Maaike J., Dirven, Linda, Taphoorn, Martin J.B.
Publicado 2020

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?

por Oort, Quirien, Zwinkels, Hanneke, Koekkoek, Johan A. F., Vos, Maaike J., Reijneveld, Jaap C., Taphoorn, Martin J. B., Dirven, Linda
Publicado 2022

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

por Koekkoek, Johan A. F., Dirven, Linda, Heimans, Jan J., Postma, Tjeerd J., Vos, Maaike J., Reijneveld, Jaap C., Taphoorn, Martin J. B.
Publicado 2015

Advance care planning in glioblastoma patients: development of a disease-specific ACP program

por Fritz, Lara, Zwinkels, Hanneke, Koekkoek, Johan A. F., Reijneveld, Jaap C., Vos, Maaike J., Dirven, Linda, Pasman, H. Roeline W., Taphoorn, Martin J. B.
Publicado 2019

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study

por van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Publicado 2023

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid

por van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C. M., van den Bent, Martin J., Taphoorn, Martin J. B., Koekkoek, Johan A. F.
Publicado 2021

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study

por van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Publicado 2022

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

por van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kerkhof, Melissa, Kouwenhoven, Mathilde C.M., van den Bent, Martin J., Taphoorn, Martin J.B., Koekkoek, Johan A.F.
Publicado 2023

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study

por Koekkoek, Johan A F, Kerkhof, Melissa, Dirven, Linda, Heimans, Jan J, Postma, Tjeerd J, Vos, Maaike J, Bromberg, Jacoline E C, van den Bent, Martin J, Reijneveld, Jaap C, Taphoorn, Martin J B
Publicado 2014

Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort stu...

por van Opijnen, Mark P., Broekman, Marike L. D., de Vos, Filip Y. F., Cuppen, Edwin, van der Hoeven, Jacobus J. M., van Linde, Myra E., Compter, Annette, Beerepoot, Laurens V., van den Bent, Martin J., Vos, Maaike J., Fiebrich, Helle-Brit, Koekkoek, Johan A. F., Hoeben, Ann, Kho, Kuan H., Driessen, Chantal M. L., Jeltema, Hanne-Rinck, Robe, Pierre A. J. T., Maas, Sybren L. N.
Publicado 2022